HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walgreens Grows Internationally With Alliance Boots Stake

This article was originally published in The Pink Sheet Daily

Executive Summary

Walgreens is acquiring 45% of the U.K.-based international retailer and wholesaler Alliance Boots, which runs pharmacies in 11 countries, with an option to acquire the entire firm in three years.

You may also be interested in...



Express Scripts Dispute With Walgreens Spotlights PBMs’ Thirst For Deeper Discounts

The contracting dispute between the drug chain and PBM may also presage tougher negotiations ahead for biopharmaceutical companies, particularly if Express Scripts is successful in its bid to acquire rival PBM Medco.

Cardinal’s China Operations Running “Ahead Of Plan,” More Expansion Ahead

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS124583

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel